A detailed history of Pathstone Holdings, LLC transactions in Geron Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 21,147 shares of GERN stock, worth $78,455. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,147
Previous 19,026 11.15%
Holding current value
$78,455
Previous $80,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$4.17 - $4.99 $8,844 - $10,583
2,121 Added 11.15%
21,147 $96,000
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $356 - $585
115 Added 0.61%
19,026 $80,000
Q1 2024

May 13, 2024

BUY
$1.75 - $3.44 $124 - $244
71 Added 0.38%
18,911 $62,000
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $32,781 - $43,520
18,840 New
18,840 $39,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.4B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.